The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

theraly.com

Stage

Seed - II | Alive

Total Raised

$800K

About Theraly Pharmaceuticals

Theraly is a product focused pharmaceutical company with a goal to efficiently generate medically important, stable, and long-acting therapies. Theraly enables products using its proprietary platform technology (4G-PEG) that can empower short-acting peptides and proteins by increasing their half-lives while maintaining potency. The company's lead program: TLY012, (a recombinant human protein) is a preclinical stage product in development for organ fibrosis. TLY012, has shown therapeutic efficacy in a number of pre-clinical models of organ fibrosis, autoimmune/inflammatory conditions, and in oncology. In diabetes, its lead product Olaedin is a long-acting form of exenatide that utilizes our 4G-PEG technology. Olaedin can be administered as a once-weekly or once-monthly s.c dose without using recombinant technology or depot systems. Theraly has enabled multiple additional products using its 4G-PEG technology.

Theraly Pharmaceuticals Headquarter Location

Baltimore, Maryland,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Theraly Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Theraly Pharmaceuticals is included in 3 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

D

Diabetes

1,750 items

Theraly Pharmaceuticals Patents

Theraly Pharmaceuticals has filed 5 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Diabetes
  • G protein coupled receptors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/11/2015

4/12/2022

Clusters of differentiation, Autoimmune diseases, Immunology, Immune system, Monoclonal antibodies

Grant

Application Date

3/11/2015

Grant Date

4/12/2022

Title

Related Topics

Clusters of differentiation, Autoimmune diseases, Immunology, Immune system, Monoclonal antibodies

Status

Grant

  • Where is Theraly Pharmaceuticals's headquarters?

    Theraly Pharmaceuticals's headquarters is located at Baltimore.

  • What is Theraly Pharmaceuticals's latest funding round?

    Theraly Pharmaceuticals's latest funding round is Seed - II.

  • How much did Theraly Pharmaceuticals raise?

    Theraly Pharmaceuticals raised a total of $800K.

  • Who are the investors of Theraly Pharmaceuticals?

    Investors of Theraly Pharmaceuticals include Maryland Technology Development Corporation.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.